Placenta previaMANAGEMENT

OBSTETRIC PRESENTATIONS · 12 SECTIONS

⚲

409 items

☷ Legend

⚲

Cardiovascular Presentations71▾

Respiratory Presentations52▾

Neurological Presentations83▾

Gastrointestinal Presentations74▾

Genitourinary and Reproductive Presentations48▾

Infectious Disease Presentations148▾

Trauma Presentations89▾

Toxicologic Presentations80▾

Psychiatric Presentations26▾

Musculoskeletal and Rheumatologic Presentations96▾

Dermatology Presentations23▾

Environmental and Exposure Presentations27▾

Hematologic and Oncologic Presentations36▾

Pediatric-Specific Presentations19▾

Endocrine and Metabolic Presentations45▾

ENT and Maxillofacial Presentations27▾

Ophthalmologic Presentations19▾

Obstetric Presentations23▾

Chorioamnionitis Eclampsia Ectopic Pregnancy (Ruptured)Ectopic Pregnancy (Unruptured)HELLP Syndrome Hyperemesis gravidarum Peripartum cardiomyopathy Placenta previa Placental abruption Postpartum Endometritis Postpartum hemorrhage Postpartum infection Preeclampsia Preeclampsia-eclampsia Preterm labor Sepsis in pregnancy Septic abortion Shoulder dystocia Spontaneous Abortion (Incomplete)Spontaneous Abortion (Missed)Spontaneous Abortion (Threatened)Threatened-inevitable-incomplete abortion Umbilical cord prolapse

Systemic and Miscellaneous Presentations17▾

01Approach to the Critical Patient/attcp38

Initial priorities

›Immediate stabilization

›If hemodynamic instability, resuscitation bay

›Two large-bore IV access

›Massive transfusion protocol if ongoing hemorrhage

›Maternal vitals and shock index

›If shock index > 1, high-risk hemorrhage physiology

›If SBP < 90 mmHg or altered mental status, emergent escalation

›Fetal assessment if viable gestation

›Continuous fetal heart rate monitoring if > 24 weeks and bleeding

›If nonreassuring tracing with ongoing bleeding, prepare for delivery

›Pelvic exam safety

›No digital vaginal examination until placenta location confirmed

›Speculum exam only for alternative source if placenta location unknown and unstable bleeding

›Immediate imaging

›Transvaginal ultrasound for placental edge to internal cervical os distance

›If placenta accreta spectrum risk factors, targeted ultrasound with color Doppler

›Team activation triggers

›If heavy bleeding, obstetrics and anesthesia at bedside

›If suspected placenta accreta spectrum, multidisciplinary hemorrhage plan

Hemorrhage framework

›Hemorrhage control strategy

›If active heavy bleeding, delivery threshold lower than gestational targets

›If maternal instability, immediate cesarean regardless of gestational age

›If fetal compromise with ongoing bleeding, immediate cesarean if viable

›Blood product strategy

›Type and crossmatch with anticipated large-volume transfusion

›Balanced transfusion strategy during massive hemorrhage

02History/hx44

Presentation pattern

›Bleeding phenotype

›Onset timing

›Gestational age at first bleed

›Sudden versus intermittent bleeding

›Bleeding characteristics

›Painless bleeding

›Clots

›Associated symptoms

›Abdominal pain or uterine tenderness

›Contractions

›Rupture of membranes

›Fetal concerns

›Decreased fetal movement

›Prior nonreassuring testing

Risk factors and modifiers

›Placenta previa and accreta risks

›Prior cesarean delivery count

›Increasing accreta risk with previa plus prior cesarean deliveries

›Prior classical cesarean or uterine surgery

›Prior placenta previa

›Recurrence risk

›Prior uterine instrumentation

›Dilation and curettage history

›Myomectomy history

›Multifetal gestation

›Increased placental surface area

›Maternal factors

03Physical Exam/exam30

Maternal assessment

›Hemodynamic and bleeding assessment

›Vitals and shock physiology

›Orthostasis

›Tachycardia

›Volume status

›Capillary refill and skin perfusion

›Mental status and urine output

›Abdominal exam

›Uterine tone

›Uterine tenderness

›Contraction pattern

›External bleeding quantification

›Pad counts and saturation rate

›Visible ongoing hemorrhage

Pelvic examination safety

›Pelvic exam approach

›Speculum exam indications

›If placenta previa not yet confirmed and alternative sources suspected

›If concern for laceration, cervicitis, or rupture of membranes assessment

›Digital exam prohibition

›No digital cervical examination until placenta previa excluded on imaging

›Cervical findings on speculum

›Active bleeding source appearance

›Cervical dilation visual estimate only

Fetal and uterine status

›Fetal assessment

›Fetal heart rate category

04Differential Diagnosis/ddx41

Life-threatening third-trimester bleeding

›Obstetric hemorrhage diagnoses

›Placenta previa

›ICD-10

›O44.0 placenta previa with hemorrhage

›O44.1 placenta previa without hemorrhage

›SNOMED CT concept

›Placenta previa

›Placental abruption

›ICD-10

›O45.- premature separation of placenta

›Key differentiators

›Painful bleeding

›Uterine tenderness and hypertonus

›Vasa previa

›ICD-10

›O69.4 labor and delivery complicated by vasa previa

›Key differentiators

›Bleeding after rupture of membranes

›Rapid fetal compromise disproportionate to maternal bleeding

›Placenta accreta spectrum

›ICD-10

›O43.2 placenta accreta spectrum

›Key differentiators

›Previa with prior cesarean

›Abnormal placental lacunae and interface on imaging

›Uterine rupture

›Key differentiators

05Laboratory Tests/lt30

Initial hemorrhage labs

›Hemorrhage and anemia evaluation

›Complete blood count for bleeding severity

›Hemoglobin trend for occult blood loss

›Platelet count for transfusion planning

›Type and screen or type and crossmatch

›Crossmatch volume based on bleeding severity and accreta concern

›Antibody screen relevance for transfusion compatibility

›Coagulation profile if moderate-to-severe bleeding

›PT and INR for coagulopathy screen

›aPTT for anticoagulant effect or coagulopathy

›Fibrinogen for obstetric hemorrhage physiology

›Falling fibrinogen as early severe hemorrhage marker

›If low fibrinogen with active bleeding, escalation of blood products

Targeted tests

›Pregnancy-specific modifiers

›Kleihauer-Betke or fetal screen if Rh-negative and significant bleeding

›Rh immune globulin dose adjustment for large fetomaternal hemorrhage

›Basic metabolic panel if massive hemorrhage

›Potassium and calcium shifts during transfusion

›Creatinine for end-organ perfusion context

›Lactate if shock physiology

›Trend for adequacy of resuscitation

Interpreting results and pitfalls

›Lab interpretation pearls

›Hemoglobin may lag early hemorrhage

›Clinical status over single hemoglobin value

›Pregnancy baseline changes

06Diagnostic Tests/dt44

Scoring Systems

›Risk stratification tools

›Placenta accreta spectrum risk stratification

›Previa plus prior cesarean deliveries as highest-risk phenotype

›Prior uterine surgery as risk amplifier

›Ultrasound-based accreta indices

›Placenta Accreta Index concept

›Intended use for predicting accreta probability and surgical planning

›Hemorrhage severity estimation

›Shock index as rapid bedside severity marker

›Trend over single value during ongoing bleeding

MRI

›Advanced placental imaging

›Indications

›Equivocal ultrasound for placenta accreta spectrum

›Posterior placenta with suboptimal ultrasound windows

›Findings supporting invasive placentation

›Abnormal placental bulge

›Dark intraplacental bands on T2-weighted imaging

›Operational considerations

›Best interpreted with experienced radiology and MFM input

›Not for acute hemorrhage triage

›Limited pregnancy role

›General principle

›Avoid fetal radiation unless maternal life-threatening indication

›Potential postpartum or nonpregnancy indications

›If postpartum hemorrhage with unclear source and unstable, CT angiography for interventional planning

07Disposition/dispo26

Level of care decisions

›Hospitalization versus outpatient management

›Admission indications

›Active bleeding

›Recurrent bleeding episodes

›Hemodynamic instability or anemia requiring transfusion

›Preterm labor with bleeding

›Limited access to emergent care

›Outpatient eligibility after stabilization

›No active bleeding for a sustained observation period

›Reliable transportation and support

›Close follow-up and rapid return capability

›Monitoring level

›Continuous fetal monitoring during acute bleeding if viable

›Antepartum unit monitoring after stabilization

Delivery timing and transfer

›Timing framework

›Scheduled cesarean for persistent placenta previa

›Typical window 36 to 37 weeks if stable and no major bleeding history

›Earlier delivery if recurrent or heavy bleeding

›Preterm delivery triggers

›Life-threatening maternal hemorrhage

›Persistent nonreassuring fetal status

›Labor onset with complete or partial previa

›Transfer criteria

›Suspected placenta accreta spectrum to tertiary center

›Anticipated massive transfusion and need for critical care

›Need for interventional radiology or complex surgical support

08Treatment/t66

Acute bleeding management

›Immediate management bundle

›If active significant bleeding, NPO

›Aspiration risk reduction for possible emergent surgery

›Anesthesia notification

›IV access and resuscitation

›Crystalloid as bridge to blood products

›Early blood products for ongoing hemorrhage

›Rh immune globulin for Rh-negative

›300 micrograms IM within 72 hours for fetomaternal hemorrhage prophylaxis

›Additional dosing guided by fetal screen or Kleihauer-Betke if large hemorrhage

›Contraction management

›If uterine contractions with mild bleeding and preterm gestation, short-term tocolysis may be used selectively

›If ongoing heavy bleeding, avoid tocolysis and proceed toward delivery planning

Medications and transfusion protocols

›Antenatal corticosteroids

›Betamethasone IM 12 mg

›Second dose 12 mg IM in 24 hours

›Use when risk of preterm delivery within 7 days and gestational age criteria met

›Magnesium sulfate for fetal neuroprotection

›If anticipated preterm delivery at very preterm gestation per local protocol

›Loading dose 4 g IV over 20 to 30 minutes

›Maintenance 1 g/hour IV until delivery or time limit per protocol

›Tranexamic acid for postpartum hemorrhage context

›If postpartum hemorrhage occurs after delivery

›TXA 1 g IV over 10 minutes

›Second dose 1 g IV if bleeding continues after 30 minutes or restarts within 24 hours

›Packed red blood cells

›If symptomatic anemia or ongoing hemorrhage

›Transfusion target based on hemodynamics and ongoing loss

›Avoid delay for lab confirmation in unstable hemorrhage

›Massive transfusion protocol

›If ongoing life-threatening bleeding

›Balanced component therapy per institutional ratios

›Calcium replacement during large-volume transfusion

›Fibrinogen replacement

›If hypofibrinogenemia with active bleeding

›Cryoprecipitate dosing per institutional protocol

›Fibrinogen concentrate if available per institutional protocol

Delivery and operative planning

›Cesarean delivery planning

›Operative timing individualized

›Stable persistent previa planned cesarean in late preterm to early term window

›Earlier cesarean for recurrent bleeding or unstable course

›Surgical approach considerations

›Preoperative ultrasound for placental mapping

›Uterine incision away from placenta when feasible

›Postpartum hemorrhage preparation

›Uterotonics ready

›Uterine tamponade devices available

›Rapid access to blood products and hemorrhage cart

›Placenta accreta spectrum preparedness

›If suspected accreta, planned cesarean hysterectomy pathway

›Multidisciplinary team

›Blood bank coordination

›Critical care and neonatal support

›Placenta removal strategy

›Avoid forced placental separation if accreta suspected intraoperatively

›Proceed to hysterectomy plan if invasion suspected and bleeding risk high

Evidence levels and guideline mapping

›Evidence framing for ED and acute care

›No digital vaginal exam prior to ultrasound confirmation

›ACEP Level B equivalent practice standard extrapolated for harm avoidance

›Class I recommendation based on expert consensus

›Transvaginal ultrasound as diagnostic standard

›Class I recommendation based on guideline consensus

›Planned cesarean timing for stable previa

›Class IIa recommendation based on guideline consensus and cohort data

›Transfer to tertiary center for suspected accreta

›Class I recommendation based on outcomes and resource needs

09Special Populations/sp30

Pregnancy

›Obstetric-specific adaptations

›Gestational age framing

›Viability threshold for continuous fetal monitoring

›Late preterm bleeding as lower threshold for delivery decision

›Medication safety

›Avoid teratogenic drugs

›Steroids and magnesium sulfate per gestational age criteria

›Activity guidance after stabilization

›Pelvic rest recommendation

›Avoidance of digital exams and unnecessary cervical manipulation

›Placenta accreta spectrum linkage

›Previa plus prior cesarean as high-risk phenotype

›Planned delivery at experienced center if suspected

Geriatric

›Advanced maternal age considerations

›Higher previa prevalence in older gravidas

›Increased risk of comorbidities affecting anesthesia planning

›Hemorrhage tolerance

›Lower physiologic reserve with anemia

›Earlier transfusion threshold if symptomatic or cardiac disease

›Anticoagulant use

›Higher likelihood of antiplatelet therapy

›Perioperative reversal planning if urgent delivery

Pediatrics

›Adolescent pregnancy considerations

›Social support and safeguarding

›Reliable transportation and safe home environment for outpatient plan

10Background/b24

Epidemiology

›Condition frequency and risk profile

›Incidence range

›Placenta previa occurs in a small minority of pregnancies

›Risk increases with prior cesarean delivery

›Natural course

›Many midtrimester low-lying placentas resolve with uterine growth

›Persistence more likely when placenta overlies internal os later in gestation

Pathophysiology

›Mechanism of bleeding

›Lower uterine segment development and cervical change

›Placental attachment near os predisposes to shearing

›Bleeding often painless from disrupted maternal vessels

›Link to accreta

›Prior uterine scar with previa predisposes to abnormal placental invasion

›Placenta accreta spectrum increases massive hemorrhage risk

Therapeutic Considerations

›Management principles

›Hemorrhage prevention

›Avoid cervical manipulation

›Planned cesarean before labor onset for persistent previa

›Maternal versus fetal risk balancing

›Delivery for maternal instability regardless of gestational age

›Expectant management when stable to reduce prematurity

›Resource intensity

›Blood bank coordination central to safe outcomes

›Multidisciplinary planning for suspected accreta

11Patient Discharge Instructions/pdi24

copy discharge instructions

›Discharge guidance for stable patients

›Return immediately for bleeding

›Any vaginal bleeding

›Bleeding soaking a pad in 1 hour

›Passage of clots

›Return immediately for maternal symptoms

›Dizziness or fainting

›Shortness of breath

›Chest pain

›Severe weakness

›Return immediately for fetal concerns

›Decreased fetal movement

›Persistent contractions or cramping

›Fluid leakage

›Activity restrictions

›Pelvic rest

›Avoid intercourse

›Avoid inserting anything into vagina

›Follow-up plan

›Obstetric follow-up within timeframe specified by treating team

›Scheduled ultrasound follow-up for placental position

›Emergency readiness

›Keep hospital contact numbers accessible

›Transportation plan for urgent return

12References/r12

Clinical guidelines and consensus

›Society for Maternal-Fetal Medicine Consult Series guidance on late preterm bleeding and delivery thresholds

›Third-trimester bleeding framework for 34 0/7 to 36 6/7 weeks

›Delivery threshold individualized by stability and etiology

›Royal College of Obstetricians and Gynaecologists Green-top Guideline No. 27a

›Placenta praevia and placenta accreta diagnosis and management pathway

›Delivery planning in units with blood and critical care access

›ACOG Obstetric Care Consensus on placenta accreta spectrum

›Planned delivery window for suspected accreta spectrum at experienced centers

›Multidisciplinary team recommendation

›Evidence summaries and reviews

›StatPearls placenta previa review for presentation patterns and accreta linkage

›Institutional protocols for follow-up ultrasound timing and hemorrhage lab interpretation

Learn More: Placenta previa→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.